SCHEMBL583655

SCHEMBL583655

O=C(O)C1CCC2(CCCO2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.44
GRM2 Q14416 2/20 0.44
GRM3 Q14832 2/20 0.44
GRM4 Q14833 2/20 0.44
LMNA P02545 2/20 0.44
MTOR P42345 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A2 P05177 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
GRM8 O00222 1/20 0.44
GRM6 O15303 1/20 0.44
GRM5 P41594 1/20 0.44
GRM1 Q13255 1/20 0.44
PLCB1 Q9NQ66 1/20 0.44
TSHR P16473 1/20 0.44
OPRK1 P41145 6/20 0.39
OPRD1 P41143 3/20 0.39
OPRM1 P35372 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL583582 0.94 LMNA (0.39) ALOX15GRM2GRM3GRM4LMNA
SCHEMBL31119101 0.89 ALOX15 (0.40) ALOX15GRM2GRM3GRM4LMNA
SCHEMBL19304 0.88 TSHR (0.38) ALOX15GRM2GRM3GRM4LMNA
SCHEMBL30148928 0.88 CYP2C19 (0.44) ALOX15GRM2GRM3GRM4LMNA
SCHEMBL6682030 0.83 OPRK1 (0.36) ALOX15GRM2GRM3GRM4LMNA
SCHEMBL28710315 0.82 TSHR (0.48) ALOX15GRM2GRM3GRM4LMNA
SCHEMBL16635812 0.79 SLC6A12 (0.39) ALOX15GRM4LMNAMTORCYP2C19
SCHEMBL1933929 0.79 OPRK1 (0.34) ALOX15LMNAMTORTSHROPRK1
SCHEMBL8577511 0.79 OPRK1 (0.36) ALOX15LMNAMTORTSHROPRK1
SCHEMBL30148920 0.77 CYP2C19 (0.50) ALOX15GRM2GRM3GRM4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023224894-A1 MACROCYCLES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2023-11-23 WO disclosed
CN-115521325-A Boronic acid derivatives 首药控股(北京)股份有限公司 2022-12-27 CN disclosed
EP-2882718-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2015-06-17 EP disclosed
WO-2014023258-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2014-02-13 WO disclosed
EP-2417138-A1 PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS Schering Corporation (US) 2012-02-15 EP disclosed
WO-2011061590-A1 NOVEL CARBOXAMIDE DERIVATIVES AS HIV INHIBITORS HETERO RESEARCH FOUNDATION (IN) 2011-05-26 WO disclosed
WO-2011061590-A1 NOVEL CARBOXAMIDE DERIVATIVES AS HIV INHIBITORS HETERO RESEARCH FOUNDATION (IN) 2011-05-26 WO disclosed
EP-2285798-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA AstraZeneca AB (SE) 2011-02-23 EP disclosed
WO-2010118207-A1 PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS SCHERING CORPORATION (US) 2010-10-14 WO disclosed
WO-2009136850-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA ASTRAZENECA AB (SE) 2009-11-12 WO disclosed